Detalhe da pesquisa
1.
Phototherapy for atopic dermatitis: A survey of European practice.
J Eur Acad Dermatol Venereol
; 38(3): 521-529, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011002
2.
Nipple eczema: A systematic review and practical recommendations.
J Eur Acad Dermatol Venereol
; 37(6): 1149-1159, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695082
3.
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis.
Br J Dermatol
; 186(2): 285-294, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608623
4.
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.
Br J Dermatol
; 186(3): 453-465, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637142
5.
Sensitive skin: A relevant syndrome, be aware.
J Eur Acad Dermatol Venereol
; 36 Suppl 5: 3-5, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315153
6.
Determinants of costs and benefits in atopic dermatitis routine care in Germany.
J Eur Acad Dermatol Venereol
; 36(9): 1450-1455, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460522
7.
An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis.
J Eur Acad Dermatol Venereol
; 36(9): 1486-1496, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490395
8.
Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options.
J Eur Acad Dermatol Venereol
; 36(9): 1432-1449, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575442
9.
Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry.
J Eur Acad Dermatol Venereol
; 36(3): 413-421, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743344
10.
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations.
J Eur Acad Dermatol Venereol
; 36(11): 1904-1926, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056736
11.
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
J Eur Acad Dermatol Venereol
; 36(9): 1409-1431, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980214
12.
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
Br J Dermatol
; 184(3): 437-449, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33000465
13.
Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine care.
J Eur Acad Dermatol Venereol
; 35(6): 1346-1356, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651457
14.
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study.
J Eur Acad Dermatol Venereol
; 35(7): 1562-1568, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711179
15.
Position statement on the role of nurses in therapeutic patient education in atopic dermatitis.
J Eur Acad Dermatol Venereol
; 35(11): 2143-2148, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289187
16.
2020 European guideline on the management of genital molluscum contagiosum.
J Eur Acad Dermatol Venereol
; 35(1): 17-26, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881110
17.
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.
J Eur Acad Dermatol Venereol
; 35(7): 1543-1552, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33834521
18.
Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
Br J Dermatol
; 182(6): e186-e209, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32476149
19.
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.
Br J Dermatol
; 182(6): 1331-1342, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31677162
20.
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).
Br J Dermatol
; 182(5): 1120-1135, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31407311